Blueprint Medicines shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $222M | 2.5M | 88.51 |
| 2024-12-31 | $101M | 1.2M | 87.22 |
| 2024-09-30 | $113M | 1.2M | 92.50 |
| 2024-06-30 | $132M | 1.2M | 107.78 |
| 2024-03-31 | $124M | 1.3M | 94.86 |
| 2023-12-31 | $140M | 1.5M | 92.24 |
| 2023-09-30 | $85M | 1.7M | 50.22 |
| 2023-06-30 | $102M | 1.6M | 63.20 |
| 2023-03-31 | $69M | 1.5M | 46.74 |
| 2022-12-31 | $63M | 1.4M | 43.81 |
| 2022-06-30 | $87M | 1.7M | 50.51 |
| 2022-03-31 | $107M | 1.7M | 63.88 |
| 2021-12-31 | $176M | 1.6M | 107.11 |
| 2021-03-31 | $150M | 1.5M | 97.23 |
| 2020-12-31 | $169M | 1.5M | 112.31 |
| 2020-09-30 | $125M | 1.4M | 91.19 |
| 2020-06-30 | $87M | 1.1M | 78.00 |
| 2020-03-31 | $57M | 970k | 58.47 |
| 2019-12-31 | $9.1M | 114k | 80.11 |
| 2019-09-30 | $8.9M | 122k | 73.47 |
| 2019-06-30 | $11M | 113k | 92.94 |
| 2019-03-31 | $8.9M | 111k | 80.04 |
| 2018-12-31 | $4.3M | 79k | 53.92 |
| 2018-09-30 | $6.0M | 77k | 78.07 |
| 2018-06-30 | $4.6M | 73k | 63.47 |
| 2018-03-31 | $4.8M | 53k | 91.70 |
| 2017-12-31 | $1.6M | 21k | 75.40 |
| 2017-06-30 | $541k | 11k | 51.21 |
| 2017-03-31 | $5.8M | 145k | 40.00 |
| 2016-12-31 | $4.7M | 167k | 28.02 |
| 2016-09-30 | $4.9M | 165k | 29.69 |
| 2016-06-30 | $3.2M | 159k | 20.25 |
| 2016-03-31 | $1.4M | 80k | 18.04 |
| 2015-12-31 | $2.1M | 79k | 26.35 |
| 2015-09-30 | $2.0M | 92k | 21.34 |
| 2015-06-30 | $6.9M | 262k | 26.53 |